Braden Michael Leonard - Sep 5, 2024 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role: 10%+ Owner
Signature: Braden M Leonard
Stock symbol: TLIS
Transactions as of: Sep 5, 2024
Transactions value $: $44,240
Form type: 4
Date filed: 9/9/2024, 04:24 PM
Previous filing: Sep 5, 2024
Next filing: Sep 16, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TLIS	Common Stock	Purchase	$7.14K	+5.1K	+2.33%	$1.40	224K	Sep 5, 2024	Holding of BML Investment Partners, L.P.	F1
transaction	TLIS	Common Stock	Purchase	$37.1K	+25K	+11.18%	$1.48	249K	Sep 6, 2024	Holding of BML Investment Partners, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Content

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.